Questcor Pharmaceuticals, Inc. (AMEX: QSC) 17.3% HIGHER; reports Q4 EPS of $0.45 compared to a $0.06 loss for the same period last year.
Revenues were $27.1 million for Q4 compared to $3.4 million for the same period last year. Separately, the QSC board approves the repurchase plan for up to 7 million shares.
Obagi Medical Products, Inc. (NASDAQ: OMPI) 12% LOWER; reports Q4 EPS of $0.21, cents better than the analyst estimate of $0..
Revenues for the quarter were $27.3...
Post new comment